THE WORLD’S FIRST HYBRID CLOSED LOOP SYSTEM
MINIMED® 670G SYSTEM
The first and only system that constantly self-adjusts to automatically keep your sugar levels in range, based on how you live your everyday life.
Indicated for type 1 patients, 14 and over. WARNING: may not be safe for use in children under 7 or in those requiring less than 8 units of insulin per day.
The MiniMed 670G system with SmartGuard® HCL technology offers two new levels of personalization:
• The Suspend before low option avoids lows and rebound highs proactively by automatically stopping insulin 30 minutes before you reach your pre-selected low limits, then automatically restarts insulin when your levels recover, all without bothersome alerts.
• The Auto Mode option automatically adjusts your basal insulin delivery every 5 minutes based on your sugar levels to keep you in target range, all day and night.
• Guardian® sensor 3 continuous glucose monitoring sensor. Introducing the most accurate sensor from Medtronic, now with up to 7 day wear and easy insertion. It is the FIRST and ONLY continuous glucose monitoring sensor FDA approved and trusted to control insulin dosing.
Exclusive CONTOUR®NEXT LINK 2.4 meter1 Get easy and accurate CGM calibration, insulin dosing and remote bolusing with our exclusive meter.
WHAT ARE OTHERS SAYING ABOUT
THE MINIMED® 670G SYSTEM?
“A life-changing breakthrough.”
“This device will mean peace of mind, in knowing a person will be in normal blood sugar range a great majority of the time,”
One of the best 25 innovations
“A groundbreaking new device could change the lives of millions of people living with diabetes.”
De första 1000 patienterna i USA har nu börjat använda 670G
När blir den CE märkt i Europa?
När kommer den till Sveriger?
www red DiabetologNytt